Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Sutro Biopharma (STRO) over the last 8 years, with Q3 2025 value amounting to 0.4.

  • Sutro Biopharma's Asset Utilization Ratio rose 2235.74% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 2235.74%. This contributed to the annual value of 0.14 for FY2024, which is 5871.34% down from last year.
  • Per Sutro Biopharma's latest filing, its Asset Utilization Ratio stood at 0.4 for Q3 2025, which was up 2235.74% from 0.32 recorded in Q2 2025.
  • Over the past 5 years, Sutro Biopharma's Asset Utilization Ratio peaked at 0.4 during Q3 2025, and registered a low of 0.11 during Q3 2023.
  • Over the past 5 years, Sutro Biopharma's median Asset Utilization Ratio value was 0.17 (recorded in 2021), while the average stood at 0.22.
  • As far as peak fluctuations go, Sutro Biopharma's Asset Utilization Ratio surged by 19984.85% in 2024, and later tumbled by 6250.55% in 2025.
  • Sutro Biopharma's Asset Utilization Ratio (Quarter) stood at 0.17 in 2021, then dropped by 3.33% to 0.17 in 2022, then surged by 103.0% to 0.34 in 2023, then tumbled by 62.12% to 0.13 in 2024, then surged by 208.47% to 0.4 in 2025.
  • Its Asset Utilization Ratio stands at 0.4 for Q3 2025, versus 0.32 for Q2 2025 and 0.13 for Q1 2025.